Cellectis S.A. (CLLS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 6M 12M 18M Q2 '19: 1.2M Q2 '20: 2.9M Q2 '21: 11.2M Q2 '22: 1.3M Q2 '23: 178K Q2 '24: 8.1M Q2 '25: 16.7M Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25

Gross Profit Quarterly

-3M -2M -1M 0 1M 2M 3M Q2 '19: 337K Q2 '20: -2.9M Q2 '21: -578K Q2 '22: 978K Q2 '23: 123K Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-45M -30M -15M 0 15M 30M 45M Q2 '21: -37.5M Q2 '22: -27.3M Q1 '23: -23.4M Q2 '23: -23.6M Q3 '23: -20.7M Q4 '23: -29.6M Q2 '24: -17.2M Q2 '25: -9.6M Q2 '21 Q2 '22 Q1 '23 Q2 '23 Q3 '23 Q4 '23 Q2 '24 Q2 '25

Net Income Quarterly

-45M -30M -15M 0 15M 30M 45M Q2 '21: -41.6M Q2 '22: -19.5M Q1 '23: -32.5M Q2 '23: -16.6M Q3 '23: -17.5M Q4 '23: -41.8M Q2 '24: -25.3M Q2 '25: -23.7M Q2 '21 Q2 '22 Q1 '23 Q2 '23 Q3 '23 Q4 '23 Q2 '24 Q2 '25

Cost of Revenue Quarterly

0 4M 8M 12M Q2 '19: 815K Q2 '20: 5.8M Q2 '21: 11.8M Q2 '22: 329K Q2 '23: 55K Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23

Operating Cash Flow Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Free Cash Flow Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 35M 70M 105M Q2 '19: 42.4M Q2 '20: 42.5M Q2 '21: 45.5M Q2 '22: 45.5M Q2 '23: 55.6M Q2 '24: 89.9M Q2 '19 Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.10 -1.40 -0.70 0.00 0.70 1.40 2.10 Q4 '23: -1.77 Q4 '23

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.